Companies which are more than 50% undervalued based on analyst price target.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
HUBN New	CHF 175.60	-15.2%	62.3%	CHF 3.3b	CHF 274.00	44.5	38.3%	1.1%	Capital Goods
NEAG	CHF 30.30	-0.3%	-5.9%	CHF 991.0m	CHF 60.00	6.5	-14.1%	3.0%	Utilities
CMHC	CHF 58.20	-4.4%	4.1%	CHF 978.1m	CHF 122.09	10.4	55.1%	3.4%	Pharmaceuticals & Biotech
KURN New	CHF 22.60	-1.7%	-17.6%	CHF 863.3m	CHF 33.92	124.3	58.6%	n/a	Pharmaceuticals & Biotech
MEDX	CHF 8.99	-3.1%	-15.7%	CHF 368.4m	CHF 14.97	3659.5	64.6%	1.1%	Healthcare
VETN	CHF 17.32	-3.7%	-42.5%	CHF 345.3m	CHF 28.50	90.4	85.4%	2.9%	Materials
MIKN	CHF 16.25	-2.4%	-12.5%	CHF 277.8m	CHF 29.80	9.7	-1.0%	3.7%	Capital Goods
PEAN	CHF 4.72	-6.5%	-28.8%	CHF 269.5m	CHF 7.87	1.9	104.4%	0%	Real Estate Management and Development
NWRN	CHF 12.96	10.6%	68.3%	CHF 266.3m	CHF 47.48	15.0	50.2%	n/a	Pharmaceuticals & Biotech
SANN	CHF 16.96	6.8%	20.6%	CHF 251.6m	CHF 27.50	3.4	18.6%	n/a	Pharmaceuticals & Biotech
BIOV	CHF 25.10	-4.2%	-2.7%	CHF 156.6m	CHF 58.26	46.4	-14.2%	n/a	Pharmaceuticals & Biotech
VARN	CHF 13.20	3.5%	-33.8%	CHF 133.7m	CHF 25.18	1.5	7.0%	0%	Real Estate Management and Development
LMN	CHF 12.30	-0.8%	-22.9%	CHF 131.5m	CHF 19.37	42.1	60.9%	3.1%	Consumer Services
MOLN	CHF 3.48	6.7%	19.4%	CHF 129.8m	CHF 9.00	1.9	16.7%	n/a	Pharmaceuticals & Biotech
XLS	CHF 15.35	-4.1%	-26.9%	CHF 91.8m	CHF 31.00	317.9	-6.9%	n/a	Pharmaceuticals & Biotech
MMTX	CHF 0.21	-8.6%	n/a	CHF 31.3m	CHF 2.73	49.6	87.7%	n/a	Pharmaceuticals & Biotech
ASWN	CHF 0.58	-7.1%	-44.3%	CHF 8.2m	CHF 2.00	0.4	74.2%	n/a	Media

Top Stock Picks from Analysts